Influence of Molecular Status on Recurrence Site in Patients Treated for a Stage III Colon Cancer: a Post Hoc Analysis of the PETACC-8 Trial.

Matthieu BruzziE AuclinR Lo DicoT VoronM KarouiE EspinF CianchiJ WeitzA BuggenhoutR MalafosseF DenimalK Le MalicotD VernereyR DouardJ F EmileC LepageP Laurent-PuigJ Taieb

Published in: Annals of surgical oncology (2019)

Microsatellite, RAS and BRAFV600E status influences recurrence rates in stage III CC patients. However, only microsatellite status seems to be associated with specific recurrence patterns. More than two recurrence sites and recurrence in the peritoneum were associated with poorer SAR.

Keyphrases

free survival
newly diagnosed
end stage renal disease
clinical trial
prognostic factors